Literature DB >> 22018784

Molecular epidemiology, genome characterization, and recombination event of human parechovirus.

Thaweesak Chieochansin1, Preeyaporn Vichiwattana, Sumeth Korkong, Apiradee Theamboonlers, Yong Poovorawan.   

Abstract

Human Parechovirus (HPeV), a member of the Picornaviridae family, is an infectious agent mostly affecting children. There are 16 recognized genotypes which have globally spread. This study incorporated a total of 2957 nasopharyngeal (NP) swab and 759 fecal samples that were collected from different parts of Thailand. The NP of HPeV was detected in 0.4% of NP swab and 6.1% of fecal samples. The majority of HPeV infections occur in infants below the age of 2 years, while infections were detected in children above the age of 10 years as well. Various genotypes comprising 1A, 1B, 2, 3, 4, 5, 6, 10 and 14 have been characterized. This study revealed recombination events in 16 samples in which HPeV1B was shown as the highest frequency. In conclusion, HPeV can be detected in both the respiratory and GI tract. Moreover, HPeV which circulates in Thailand is highly diverse and subject to recombination. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22018784     DOI: 10.1016/j.virol.2011.09.021

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants.

Authors:  Laudi Olijve; Lance Jennings; Tony Walls
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

2.  Human parechovirus in respiratory specimens from children in Kansas City, Missouri.

Authors:  Justin Sharp; Jeremiah Bell; Christopher J Harrison; W Allan Nix; M Steven Oberste; Rangaraj Selvarangan
Journal:  J Clin Microbiol       Date:  2012-09-26       Impact factor: 5.948

3.  Complete genome sequence of a novel type of human parechovirus strain reveals natural recombination events.

Authors:  Guangming Sun; Yong Wang; Gang Tao; Quan Shen; Weiping Cao; Xianlu Chang; Wen Zhang; Chen Shao; Miaoli Yi; Shihe Shao; Yan Yang
Journal:  J Virol       Date:  2012-08       Impact factor: 5.103

4.  Genome analysis revealed novel genotypes and recombination of the human parechoviruses prevalent in children in Eastern China.

Authors:  Xiangyang Zhao; Yongqiang Shi; Yu Xia
Journal:  Gut Pathog       Date:  2016-11-08       Impact factor: 4.181

5.  An outbreak of severe infections among Australian infants caused by a novel recombinant strain of human parechovirus type 3.

Authors:  Tiffanie M Nelson; Peter Vuillermin; Jason Hodge; Julian Druce; David T Williams; Rekha Jasrotia; Soren Alexandersen
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

Review 6.  Elucidation and clinical role of emerging viral respiratory tract infections in children.

Authors:  Inge Ahout; Gerben Ferwerda; Ronald de Groot
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Phylogenetic molecular evolution and recombination analysis of complete genome of human parechovirus in Thailand.

Authors:  Thaweesak Chieochansin; Jiratchaya Puenpa; Yong Poovorawan
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

8.  Virome of respiratory secretion from children with unknown etiological acute respiratory disease revealed recombinant human parechovirus and other significant viruses.

Authors:  Ying Liu; Hao Wang; Jie Yang; Jian Zeng; Guang-Ming Sun
Journal:  Virol J       Date:  2021-06-09       Impact factor: 4.099

9.  Identification and manipulation of the molecular determinants influencing poliovirus recombination.

Authors:  Charles Runckel; Oscar Westesson; Raul Andino; Joseph L DeRisi
Journal:  PLoS Pathog       Date:  2013-02-07       Impact factor: 6.823

10.  Changes in human parechovirus profiles in hospitalized children with acute gastroenteritis after a three-year interval in Lanzhou, China.

Authors:  Ying Guo; Zhaojun Duan; Yuan Qian
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.